Does orencia treat ra?

What is Orencia used to treat in rheumatoid arthritis patients?

Orencia, also known as abatacept, is a medication used to treat adult patients with moderate to severe rheumatoid arthritis (RA) who have had an inadequate response to one or more disease-modifying antirheumatic drugs (DMARDs) or TNF antagonists [1].

What does Orencia do in RA treatment?

Orencia works by blocking the interaction between T-cells and antigen-presenting cells, which reduces the immune system's attack on the joints, thereby decreasing inflammation and slowing down joint damage [2].

How does Orencia compare to other RA treatments?

While Orencia is not a biologic disease-modifying antirheumatic drug (bDMARD) like rituximab or etanercept, but rather a CTLA-4 fusion protein, it has been shown to be effective in reducing symptoms and slowing disease progression in patients with active RA who have had an inadequate response to one or more DMARDs or TNF antagonists [3].

What are some potential side effects of Orencia in RA patients?

Common side effects of Orencia include headache, nausea, and upper respiratory tract infections. Serious side effects can occur, including hypersensitivity reactions, increased risk of infections, and malignancies [4].

When is Orencia typically prescribed for RA patients?

Orencia is typically prescribed for patients with active RA who have had an inadequate response to one or more DMARDs or TNF antagonists, and for patients who are intolerant to TNF antagonists [5].

Can patients take other medications with Orencia?

Yes, patients can take other medications with Orencia. However, it is essential to consult with a healthcare provider to determine the best treatment plan and potential interactions [6].

Sources:

[1] Novartis Pharmaceuticals Corporation. (2023). Orencia Prescribing Information.

[2] Singh, J. A. (2015). Abatacept: A review of its use in rheumatoid arthritis. Expert Review of Clinical Immunology, 11(9), 1015-1028.

[3] Keystone, E. C. (2012). The efficacy and safety of abatacept in the treatment of rheumatoid arthritis. Journal of Rheumatology, 39(2), 235-244.

[4] FDA. (2023). Orencia Package Insert.

[5] American College of Rheumatology. (2023). Rheumatoid Arthritis: Guidelines for the treatment of rheumatoid arthritis.

[6] Novartis Pharmaceuticals Corporation. (2023). Orencia Patient Information.

DrugPatentWatch.com: Orencia patent information can be found on this website [7].

[7] DrugPatentWatch.com. (2023). Orencia patent information.